Dr.Reddy'S Laboratories Profile
Key Indicators
- Authorised Capital ₹ 145.00 Cr
as on 14-11-2024
- Paid Up Capital ₹ 83.44 Cr
as on 14-11-2024
- Company Age 40 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 34.23 Cr
as on 14-11-2024
- Satisfied Charges ₹ 586.71 Cr
as on 14-11-2024
- Revenue 15.91%
(FY 2024)
- Profit 66.18%
(FY 2024)
- Ebitda 40.61%
(FY 2024)
- Net Worth 18.40%
(FY 2024)
- Total Assets 19.64%
(FY 2024)
About Dr.Reddy'S Laboratories
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500124 and on the National Stock Exchange(NSE) under DRREDDY.
The Corporate was formerly known as Dr.Reddy's Laboratories P Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 145.00 Cr and a paid-up capital of Rs 83.44 Cr.
The company currently has active open charges totaling ₹34.23 Cr. The company has closed loans amounting to ₹586.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Dr.Reddy's Laboratories Ltd India are Erez Israeli as Ceo, Kumar Singh as Company Secretary, and Mannam Narasimham as Cfo. Shikha Sharma, Venkateswara Gunupati, Satish Kallam, and Seven other members serve as directors at the Company.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dr.Reddy's Laboratories Ltd offer?
Dr.Reddy'S Laboratories Ltd offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, API (Active Pharmaceutical Ingredients), Generic Pharmaceuticals, Pharmaceutical Services, Drug Development Services, Pharma & Bioanalytical Services, PCD Pharma Franchise.
Who are the key members and board of directors at Dr.Reddy'S Laboratories?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateswara Gunupati  | Managing Director | 08-Apr-1986 | Current |
| Erez Israeli | CEO | 01-Aug-2019 | Current |
| Kumar Singh | Company Secretary | 17-Mar-2022 | Current |
| Mannam Narasimham | CFO | 28-Aug-2024 | Current |
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shikha Sharma | Director | 31-Jan-2019 | Current |
| Satish Kallam | Whole-Time Director | 18-Jan-1993 | Current |
| Sanjiv Mehta | Director | Current | |
| Leo Puri | Director | 25-Oct-2018 | Current |
| Kodumudi Krishnan | Director | 07-Jan-2022 | Current |
Alpna Seth  | Director | 19-Sep-2023 | Current |
Financial Performance of Dr.Reddy'S Laboratories.
Dr.Reddy'S Laboratories Ltd, for the financial year ended 2024, experienced significant growth in revenue, with a 15.91% increase. The company also saw a substantial improvement in profitability, with a 66.18% increase in profit. The company's net worth Soared by an impressive increase of 18.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Reddy'S Laboratories?
In 2022, Dr.Reddy'S Laboratories had a promoter holding of 26.71% and a public holding of 73.29%. The company had 9 Subsidiaries and 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr.Reddy's Institute Of Life SciencesActive 21 years 2 monthsVenkateswara Gunupati and Satish Kallam are mutual person
Greenpark Hotels And Resorts LimitedActive 38 years 2 monthsVenkateswara Gunupati and Satish Kallam are mutual person
Tata Consumer Products LimitedActive 62 years 3 monthsShikha Sharma and Kodumudi Krishnan are mutual person
Charges (Loans)
₹34.23 Cr
₹586.71 Cr
Charges Breakdown by Lending Institutions
- Globaltrust Bank Ltd : 20.00 Cr
- Global Trust Bank Ltd : 7.60 Cr
- Global Tust Bank Ltd : 5.50 Cr
- Industrial Finance Corp. Of India : 0.45 Cr
- Andhra Bank : 0.25 Cr
- Others : 0.43 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Aug 1996 | Globaltrust Bank Ltd | ₹10.00 Cr | Open |
| 19 Feb 1996 | Globaltrust Bank Ltd | ₹10.00 Cr | Open |
| 20 Dec 1995 | Global Trust Bank Ltd | ₹5.00 Cr | Open |
| 04 Dec 1995 | Global Trust Bank Ltd | ₹2.60 Cr | Open |
| 06 Jul 1995 | Global Tust Bank Ltd | ₹5.50 Cr | Open |
How Many Employees Work at Dr.Reddy'S Laboratories?
Dr.Reddy'S Laboratories has a workforce of 7985 employees as of Nov 14, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Reddy'S Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Reddy'S Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
